Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 3/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 2/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28035602 | 0.82 | TDP1 (0.41) | ADRB2ALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL5068618 | 0.77 | ALDH1A1 (0.37) | ADRB2ADRB1ALDH1A1HSD17B10MAPK1 | |
| SCHEMBL18297950 | 0.76 | HSD11B1 (0.37) | ADRB2ADRB1ALDH1A1HSD17B10MAPK1 | |
| SCHEMBL10448876 | 0.76 | ALDH1A1 (0.52) | ADRB2ADRB1ALDH1A1HSD17B10MAPK1 | |
| SCHEMBL10581664 | 0.76 | CYP2A6 (0.40) | ADRB2ADRB1ALDH1A1HSD17B10MAPK1 | |
| SCHEMBL28562495 | 0.74 | MAPK1 (0.43) | ADRB2ADRB1ALDH1A1HSD17B10MAPK1 | |
| SCHEMBL3112567 | 0.73 | CA2 (0.32) | — | |
| SCHEMBL11507354 | 0.73 | ALDH1A1 (0.38) | ALDH1A1HSD17B10MAPK1HPGDBCL2L1 | |
| SCHEMBL4521012 | 0.72 | MAPK1 (0.56) | ALDH1A1MAPK1ALOX15 | |
| SCHEMBL29833702 | 0.72 | ALDH1A1 (0.46) | ALDH1A1HSD17B10MAPK1HPGDBCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7518021-B2 | Aromatic vinyl ether compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20040181098-A1 | Aromatic vinyl ether compounds | EMORY UNIVERSITY | 2004-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181098-A1 | Aromatic vinyl ether compounds | SUV39H2, SUV39H1, RAVER1 | ADRB2 733/4885ADRB1 961/4885ALDH1A1 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.